YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Feasibility, Acceptability, and Barriers to Implementation of a Geriatrics Bundle in the ICU

Not Applicable

Completed

Conditions: Intensive Care Unit Syndrome

Interventions: Other: Geriatrics Bundle

First Posted Date: 2020-12-03

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 83

Registration Number: NCT04652453

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures

Not Applicable

Recruiting

Conditions: Coronary Artery Bypass Graft Surgery
Aortic Valve Replacement

Interventions: Other: Lactated Ringer's Solution
Other: Albumin Solution

First Posted Date: 2020-12-03

Last Posted Date: 2024-06-27

Lead Sponsor: Yale University

Target Recruit Count: 400

Registration Number: NCT04652375

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Phase 4

Recruiting

Conditions: Heart Failure

Interventions: Drug: LCZ 696
Drug: Placebo
Drug: Para-aminohippurate
Drug: Iohexol
Drug: Aprepitant

First Posted Date: 2020-12-02

Last Posted Date: 2024-03-05

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT04649229

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papillomatosis Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement

Phase 2

Not yet recruiting

Conditions: Human Papilloma Virus
Recurrent Respiratory Papillomatosis

Interventions: Drug: Lenvatinib
Drug: Pembrolizumab

First Posted Date: 2020-11-27

Last Posted Date: 2024-10-01

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT04645602

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Families Coping Together With Alzheimer's Disease

Completed

Conditions: Family Research
Dementia

First Posted Date: 2020-11-24

Last Posted Date: 2024-12-18

Lead Sponsor: Yale University

Target Recruit Count: 354

Registration Number: NCT04642885

Locations: 🇺🇸
Yale school of Public Health, New Haven, Connecticut, United States

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Recruiting

Conditions: NAFLD

First Posted Date: 2020-11-18

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 260

Registration Number: NCT04634643

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Face Masks to Reduce COVID-19 in Bangladesh

Not Applicable

Completed

Conditions: Covid19

Interventions: Device: Face mask
Behavioral: Face mask awareness

First Posted Date: 2020-11-16

Last Posted Date: 2022-01-28

Lead Sponsor: Yale University

Target Recruit Count: 350000

Registration Number: NCT04630054

Locations: 🇧🇩
Innovations for Poverty Action, Dhaka, Bangladesh

Effects of Hepatic Ultrasound on Metabolic Homeostasis

Not Applicable

Completed

Conditions: Insulin Resistance
Healthy

Interventions: Procedure: Ultrasound

First Posted Date: 2020-11-10

Last Posted Date: 2024-12-16

Lead Sponsor: Yale University

Target Recruit Count: 37

Registration Number: NCT04622683

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS)

Not Applicable

Completed

Conditions: Physician Stress Levels

Interventions: Behavioral: Simulation Intervention
Behavioral: Control

First Posted Date: 2020-11-04

Last Posted Date: 2022-10-07

Lead Sponsor: Yale University

Target Recruit Count: 159

Registration Number: NCT04614844

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers

Phase 4

Active, not recruiting

Conditions: Overweight and Obesity

Interventions: Dietary Supplement: RiduZone (90% OEA)
Drug: Placebo

First Posted Date: 2020-11-03

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 120

Registration Number: NCT04614233

Locations: 🇺🇸
Modern Diet and Physiology Research Lab, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy